secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2022-02-17T23:59:59+00:00
Accession:  0000950170-22-001386
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mednax Q4 EPS $0.47 ($0.52 adj); revenue $499M; FY22 EBITDA guidance at least $270M
--------------------------------------------------------------------------------

- GAAP EPS from continuing ops $0.47 versus $0.05 in Q4 2020; adjusted EPS $0.52 versus $0.25.
- Revenue $498.5M (+20% YoY), driven by 17.6% same-unit growth (volume +6.3%, reimbursement +11.3%).
- Adjusted EBITDA $81M in Q4 ($58.3M prior year); full-year 2021 $265.5M.
- Preliminary 2022 adjusted EBITDA guidance at least $270M, excluding CARES Act funds.
- Post-quarter refinancing: issued $400M 5.375% notes due 2030, new $450M revolver, $250M term loan; total debt $750M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017022001386/0000950170-22-001386-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017022001386/md-20220217.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-001386

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer